T-Therapeutics is based in Cambridge, England. It has raised $91M in total funding. Latest round: Series A.
T-Therapeutics is based in Cambridge, England. T-Therapeutics has raised $91M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for T-Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Sofinnova Partners, F-Prime Capital, Digitalis Ventures, Cambridge Innovation Capital, Sanofi Ventures, Tencent and 2 others. 8 distinct backers are named across the disclosed rounds.
T-Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026